Skip to main content

Peer Review reports

From: Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

Original Submission
23 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Mar 2023 Author responded Author comments - Qin Feng
Resubmission - Version 3
30 Mar 2023 Submitted Manuscript version 3
6 Apr 2023 Editorially accepted
19 Apr 2023 Article published 10.1186/s12906-023-03948-3

You can find further information about peer review here.

Back to article page